What are the withdrawal and adherence rates with GLP-1 RA/insulin regimens, and how do fixed ratio combination formulations affect GI side effects sometimes encountered with GLP-1 RAs?

What are the withdrawal and adherence rates with GLP-1 RA/insulin regimens, and how do fixed ratio combination formulations affect GI side effects sometimes encountered with GLP-1 RAs?

What are the withdrawal and regimen adherence rates with the GLP-1 RA/insulin regimens, and how do the fixed ratio combination formulations affect GI side effects sometimes encountered with GLP-1 RAs? Is the incidence of side effects lower?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Juan Frias, FACE, MD

Juan Frias, FACE, MD

Clinical Assistant Professor of Medicine
University of California
San Diego, California
Chief Medical Officer
National Research Institute
Los Angeles, California